Symptom-centric view

Wrong technique in device usage process

Substances reporting Wrong technique in device usage process disproportionately — ranked by ROR.

Pain Drug ineffective Off label use Fatigue Dyspnoea Acute kidney injury

showing 24 of 24

Substance ↓	ROR [95% CI]	Reports	Category	Label
umeclidinium bromide and vilanterol trifenatate —	47.6 [46.1–49.1]	4,640	algemeen	new
umeclidinium —	46.4 [45.1–47.9]	5,156	algemeen	new
somatropin Genotropin · Humatrope	38.1 [36.9–39.3]	4,890	hormones	new
olopatadine hydrochloride —	9.1 [7.7–10.7]	144	algemeen	new
olopatadine —	6.7 [5.7–7.9]	146	algemeen	new
mepolizumab —	14.4 [13.6–15.2]	1,416	algemeen	new
insulin glargine and lixisenatide —	10.6 [8.5–13.3]	77	algemeen	new
glycopyrrolate and formoterol fumarate —	60.8 [57.3–64.5]	1,267	algemeen	new
glycopyrrolate —	39.7 [37.5–42.1]	1,275	algemeen	new
fremanezumab-vfrm —	8.0 [6.9–9.2]	186	algemeen	new
formoterol fumarate —	11.6 [11.1–12.0]	2,886	algemeen	new
fluticasone propionate and salmeterol —	10.2 [9.8–10.7]	2,061	algemeen	new
fluticasone furoate, umeclidinium bromide and vilanterol trifenatate —	42.2 [40.6–43.9]	3,071	algemeen	new
fluticasone furoate and vilanterol trifenatate —	33.5 [32.1–35.0]	2,269	algemeen	new
fluticasone furoate —	39.0 [37.9–40.1]	5,767	algemeen	new
cabotegravir and rilpivirine —	10.2 [8.5–12.2]	122	algemeen	new
cabotegravir —	8.2 [7.3–9.3]	254	algemeen	new
budesonide, glycopyrrolate, and formoterol fumarate —	65.1 [61.2–69.4]	1,126	algemeen	new
benralizumab —	5.7 [5.0–6.5]	228	algemeen	new
belimumab —	24.0 [22.8–25.3]	1,477	algemeen	new
beclomethasone dipropionate hfa —	9.3 [7.1–12.2]	54	algemeen	new
aripiprazole lauroxil —	12.7 [10.6–15.3]	119	algemeen	new
albuterol sulfate —	11.7 [11.4–12.0]	6,233	algemeen	new
albuterol —	11.6 [11.3–11.9]	6,238	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).